CD38 and primary cutaneous T-cell non-Hodgkin lymphoma: Similarly, Pavlova et al. performed a comparative analysis of skin lesions between patients with CTCL and atopic dermatitis with Nanostring technology, and found higher levels of CD38 expression in the skin lesions of CTCL patients, than in benign inflammatory skin disease [44].